Susanna Amadio Selected Research

Susanna Amadio Research Topics

Disease

10	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 10/2013
8	Multiple Sclerosis 06/2022 - 06/2010
6	Neuroinflammatory Diseases 01/2022 - 09/2014
5	Disease Progression 01/2022 - 01/2016
4	Demyelinating Diseases (Demyelinating Disease) 06/2022 - 06/2010
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2021 - 01/2017
2	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2022 - 01/2017
2	Gliosis 12/2021 - 10/2013
2	Inflammation (Inflammations) 01/2017 - 01/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016 - 01/2009
2	Brain Ischemia (Cerebral Ischemia) 09/2014 - 12/2003
2	Hypoglycemia (Reactive Hypoglycemia) 10/2004 - 12/2003
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2021
1	Mason-Type Diabetes 01/2021
1	Type 2 Maturity-Onset Diabetes of the Young 01/2021
1	Hyperglycemia 01/2021
1	Genomic Instability 01/2021
1	Obesity 01/2021
1	Neoplasms (Cancer) 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Muscular Dystrophies (Muscular Dystrophy) 01/2021
1	Relapsing-Remitting Multiple Sclerosis 01/2020
1	Muscular Atrophy (Muscle Atrophy) 01/2019
1	Brain Diseases (Brain Disorder) 01/2017
1	Autoimmune Diseases of the Nervous System 09/2014
1	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2014
1	Neuralgia (Stump Neuralgia) 09/2014
1	Body Weight (Weight, Body) 10/2013
1	Ischemia 10/2007
1	Parkinson Disease (Parkinson's Disease) 09/2007
1	Brain Infarction 07/2006
1	Infarction (Infarctions) 07/2006
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2006
1	Neuroblastoma 02/2005
1	Starvation 10/2004
1	Chronic Disease (Chronic Diseases) 12/2003
1	Hypoxia (Hypoxemia) 12/2003
1	Wounds and Injuries (Trauma) 12/2003

Drug/Important Bio-Agent (IBA)

8	Pharmaceutical PreparationsIBA 06/2022 - 09/2014
6	Histamine (Histamine Dihydrochloride)FDA Link 06/2022 - 01/2016
5	Purinergic P2X7 ReceptorsIBA 09/2021 - 07/2006
4	Proteins (Proteins, Gene)FDA Link 12/2021 - 10/2004
2	CytokinesIBA 12/2021 - 01/2017
2	Pentamidine (NebuPent)FDA LinkGeneric 12/2021 - 01/2020
2	coomassie Brilliant BlueIBA 09/2021 - 09/2014
2	EnzymesIBA 01/2021 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2004
2	Clemastine (Clemastine Fumarate)FDA LinkGeneric 01/2016 - 01/2016
2	Adenosine Triphosphate (ATP)IBA 01/2009 - 12/2003
1	rupatadineIBA 06/2022
1	Amodiaquine (Camoquin)FDA Link 06/2022
1	Diphenhydramine (Benadryl)FDA LinkGeneric 06/2022
1	Histamine AgentsIBA 06/2022
1	Trimetazidine (Vastarel)IBA 01/2022
1	ONO2506IBA 12/2021
1	AntioxidantsIBA 01/2021
1	GlucokinaseIBA 01/2021
1	Advanced Glycation End ProductsIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Vitamin B 6IBA 01/2021
1	Hexosaminidase A (Hex A)IBA 01/2021
1	Nerve Growth Factors (Neurotrophins)IBA 01/2021
1	Nerve Growth Factor (NGF)IBA 01/2021
1	Retinaldehyde (Retinal)IBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2019
1	Histidine (L-Histidine)FDA Link 01/2019
1	Histamine N-MethyltransferaseIBA 01/2017
1	Histidine DecarboxylaseIBA 01/2017
1	Histamine H4 ReceptorsIBA 01/2017
1	Amine Oxidase (Copper-Containing)IBA 01/2017
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 01/2016
1	Superoxide Dismutase-1IBA 01/2016
1	Purinergic P2X1 ReceptorsIBA 10/2007
1	Oxidopamine (6 Hydroxydopamine)IBA 09/2007
1	Dopamine (Intropin)FDA LinkGeneric 09/2007
1	Cibacron Blue F 3GAIBA 07/2006
1	purinoceptor P2Y4IBA 02/2005
1	N-Methylaspartate (NMDA)IBA 10/2004
1	NMDA receptor A1IBA 10/2004
1	PotassiumIBA 12/2003
1	Glutamic Acid (Glutamate)FDA Link 12/2003

Therapy/Procedure

1	Denervation 09/2007